---
schema_version: "secwatch.filing_event.v1"
accession: "0001562762-23-000405"
form_type: "8-K"
ticker: "GMED"
cik: "0001237831"
company_name: "GLOBUS MEDICAL INC"
filed_at: "2023-11-07T23:59:59+00:00"
generated_at: "2026-06-08T13:40:51.423443+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Globus Medical Q3 revenue $383.6M (+51% YoY); raises FY revenue guidance to $1.55B

## Summary
- GAAP net income $1.0M, diluted EPS $0.01; non-GAAP diluted EPS $0.57 (+14.7% YoY).
- NuVasive merger closed Sept 1; combined results from that date drove 51% revenue increase.
- Stand-alone Globus Medical net sales $281.2M (+10.7% YoY); U.S. +8.1%, International +25.5%.
- Non-GAAP adjusted EBITDA $112.9M (29.4% of sales); free cash flow $29.0M.
- FY 2023 revenue guidance raised to $1.55B (from $1.125B); non-GAAP EPS reaffirmed at $2.30.

## SEC filing metadata
- accession: 0001562762-23-000405
- form_type: 8-K
- ticker: GMED
- cik: 0001237831
- company_name: GLOBUS MEDICAL INC
- filed_at: 2023-11-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000405/0001562762-23-000405-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000405/gmed-20231107x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001562762-23-000405
- JSON: https://secwatch.observer/filing/0001562762-23-000405.json
- Plain text: https://secwatch.observer/filing/0001562762-23-000405.txt

## Key facts
- Earnings Releases
  GLOBUS MEDICAL INC reported the quarter ended September 30, 2023 results: revenue $383.6 million, net income $1.0 million, EPS $0.01.
  - Period: the quarter ended September 30, 2023
  - Revenue: $383.6 million
  - Net income: $1.0 million
  - EPS: $0.01
  - Result: reported results
  source text: merger with NuVasive, Inc. was completed on September 1, 2023 and results presented within include NuVasive, Inc. results from that closing date .  · Worldwide net sales were $ 383.6 million , an increase of 5 1.0 % . · GAAP net income for the quarter was $ 1.0 million · GAAP d iluted earnings per share (“ EPS ”) was $0. 0 1 and non-GAAP diluted EPS was $0. 57 ·
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000405/0001562762-23-000405-index.htm
- Earnings Releases
  GLOBUS MEDICAL INC reported full year fiscal 2023 results: revenue $1.55 billion, EPS $2.30. Guidance raised.
  - Period: full year fiscal 2023
  - Revenue: $1.55 billion
  - EPS: $2.30
  - Guidance: raised
  - Result: guidance update
  source text: The Company today increased its full year fiscal 2023 revenue guidance to $1.55 billion, up from $1.125 billion, and reaffirmed non-GAAP fully diluted earnings per share guidance of $2.30.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1237831/000156276223000405/0001562762-23-000405-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.